Trends in the development of remdesivir based inventions against COVID-19 and other disorders: A patent review.

ABSTRACT: The development of remdesivir has been a breakthrough for COVID-19 treatment. It has been approved in about 50 countries, including Saudi Arabia, since 2020. The generic structure of remdesivir was first disclosed in 2009. This patent review summarizes the remdesivir based inventions to treat/prevent COVID-19 and other disorders from 2009 to May 16, 2021, emphasizing the patents related to medical and pharmaceutical sciences. The primary patents/patent applications of remdesivir are related to its compositions, new combinations with other therapeutic agents, delivery systems, and new indications. The inventive combinations have displayed synergistic effects against COVID-19, whereas the delivery systems/compositions have improved patient compliance. The inventions related to new indication

SUBMITTER: Imran M 

PROVIDER: S-EPMC8236076 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature